Amicus Fabry Disease Drug Delayed to 2020 (FOLD) | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 30 November, 2016 by The TZ Newswire Staff

Amicus Fabry Disease Drug Delayed to 2020 (FOLD)

The launch of Amicus’ Galafold drug to treat Fabry disease has been delayed until at least 2020.

See also
- Next Article How to Help Your Clients Avoid Identity Fraud
- Previous Article Watch Miley Cyrus, Pentatonix & Dolly Parton sing ‘Jolene’ on ‘The Voice’
Editorial Calender

November 2016

M T W T F S S

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30

« Oct Dec »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar